Vanguard Health Care ETF (VHT)
| Assets | $16.44B |
| NAV | $254.09 |
| Expense Ratio | 0.10% |
| PE Ratio | 28.70 |
| Shares Out | 64.69M |
| Dividend (ttm) | $3.11 |
| Dividend Yield | 1.22% |
| Ex-Dividend Date | Sep 29, 2021 |
| 1-Year Return | - |
| Volume | 124,961 |
| Open | 253.95 |
| Previous Close | 254.17 |
| Day's Range | 253.23 - 254.85 |
| 52-Week Low | 193.17 |
| 52-Week High | 265.12 |
| Beta | 0.81 |
| Holdings | 457 |
| Inception Date | Jan 26, 2004 |
About VHT
The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
Top 10 Holdings
41.05% of assets| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 7.33% |
| UnitedHealth | UNH | 6.31% |
| Pfizer | PFE | 4.14% |
| Abbott Laboratories | ABT | 3.61% |
| Thermo Fisher Scientific | TMO | 3.51% |
| AbbVie | ABBV | 3.43% |
| Eli Lilly | LLY | 3.38% |
| Danaher | DHR | 3.34% |
| Merck | MRK | 3.10% |
| Medtronic | MDT | 2.89% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 29, 2021 | $0.893 | Oct 4, 2021 |
| Jun 24, 2021 | $0.6985 | Jun 29, 2021 |
| Mar 26, 2021 | $0.635 | Mar 31, 2021 |
| Dec 17, 2020 | $0.8816 | Dec 22, 2020 |
| Sep 11, 2020 | $0.6313 | Sep 16, 2020 |
| Jun 22, 2020 | $0.7556 | Jun 25, 2020 |
News
Should You Invest in the Vanguard Health Care ETF (VHT)?
Sector ETF report for VHT
5 Top-Ranked ETFs Looking Good Following the September Slump
Take a look at some top-ranked ETFs that might help strengthen your portfolio and rake in some good returns.
TD Ameritrade: Dave Nadig Assesses The Labor Market
On Monday, ETF Trends CIO and Director of Research Dave Nadig was on hand for the TD Ameritrade Network to discuss what's happening with the labor market with host Nicole Petallides. As far as big conce...
Healthcare ETF (VHT) Hits a New 52-Week High
This healthcare ETF hits a new 52-week high. Are more gains in store for this ETF?
Healthcare ETFs on Radar As Q1 Earnings Unfold
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate...
ETFs to Gain on UnitedHealth and Change Healthcare Deal
UnitedHealth agreed to buy Change Healthcare for $7.84 billion in cash.
5 Rational Biotech Stocks to Buy
These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them. The post 5 Rational Biotech Stocks to Buy appeared first on ...
Charts Suggest Healthcare Stocks Will Remain in Focus
Chart patterns suggest that focus should expand from the biotechs and drug makers to other niche healthcare segments.
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
What Lies Ahead for Healthcare ETFs in Q2 Earnings?
The healthcare sector is expected to witness substantial earnings decline of 6.9% in the second quarter, representing the second strongest sector this earnings season.
Consumer Staples ETFs Slip As Philip Morris Drops
Philip Morris’s stock is dropping today along with the broad market as the company that makes Marlboro cigarettes told Irish retailers it made a “mistake” by showing an advertisement in the trade press ...
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Healthcare ETFs Are Hot Right Now, but Not All Are Created Equal
The coronavirus pandemic put healthcare exchange-traded funds (ETFs) in the forefront as medical providers are an essential component in the global market landscape. However, investors shouldn’t suck up...
Healthcare ETFs Looks Strong Ahead of Q1 Earnings
The healthcare sector has been on a tear driven by potential vaccines and treatments for COVID-19.
Healthcare ETFs to Gain on Progress in COVID-19 Antibody Tests
Along with molecular testing, antibody testing is gaining immense prominence as economies are struggling to reopen.
Healthcare ETFs Hold Their Ground As Stocks Selloff On Poor Data Wednesday
While stocks struggled anew on Wednesday, relinquishing most of the gains of the prior day, amid poor data and renewed coronavirus concerns, the healthcare sector had some shining stars. Shares of Johns...
